Avient Corporation logo AVNT - Avient Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 12
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $46.71 DETAILS
HIGH: $56.00
LOW: $41.00
MEDIAN: $44.00
CONSENSUS: $46.71
UPSIDE: 29.64%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Mild
Trading 1.8% above fair value
Current Price $36.03
Bear Case $28.32 21.4% downside ($28.32 - $36.03) / $36.03 = -21.4% $2.11 × 12x P/E
Fair Value $35.39 1.8% downside ($35.39 - $36.03) / $36.03 = -1.8% $2.11 × 15x P/E
Bull Case $42.47 17.9% upside ($42.47 - $36.03) / $36.03 = 17.9% $2.11 × 18x P/E

Adjust Assumptions

15.0x
2.11$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 17.1x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $46.71 from 20 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $35.39 per share.

Warnings

The company's reported profits differ from official accounting profits by 137%. Check what costs are being left out of the adjusted number.
The company pays out 123% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.
Dividend-based valuation: $24.92 (below our primary estimate by 21%). Large gaps may signal the dividend doesn't reflect full earning power.
Wall Street's average price target is $46.71 (from 20 analysts). Our estimate is 32% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples